Skip to main content
OpenTrials

Clinical trial condition

Liver Neoplasms

Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.

851 public trials 186 recruiting studies
Refine in advanced search Browse all conditions

Liver Neoplasms trial results

Active, Not Recruiting

A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

NCT06679985

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
  • University of Arizona - Cancer Center Tucson, Arizona, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • City of Hope Duarte, California, United States
View all 44 locations
View Trial Details
Active, Not Recruiting

A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma

NCT03778957

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Research Site Costa Mesa, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Orange, California, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 166 locations
View Trial Details
Active, Not Recruiting

Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC

NCT05301842

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Mobile, Alabama, United States
  • Research Site Yuma, Arizona, United States
  • Research Site Glendale, California, United States
View all 171 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis

NCT06096779

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of Southern California-Keck School of Medicine -1975 Zonal Ave Los Angeles, California, United States
  • University of Southern California Newport Beach, California, United States
View all 59 locations
View Trial Details
Active, Not Recruiting

A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer

NCT05211323

Conditions
Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +6 more
Locations
  • Sutter Auburn Faith Hospital Auburn, California, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • Palo Alto Medical Foundation-Fremont Fremont, California, United States
  • Memorial Medical Center Modesto, California, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE

NCT06040099

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Research Site Aurora, Colorado, United States
  • Research Site Gainesville, Florida, United States
  • Research Site Orlando, Florida, United States
  • Research Site Atlanta, Georgia, United States
View all 21 locations
View Trial Details

Related conditions